Home » Topics » BioWorld Science

BioWorld Science
RSS

Novel TRPC5 inhibitors show potential for the treatment of CKD

May 3, 2022

Ring Therapeutics describes in vitro system enabling human anellovirus production

May 3, 2022

ProfoundBio antibody-drug conjugate PRO-1102 shows potency in vitro and in vivo

May 3, 2022

Gilead and Dragonfly collaborate to advance NK cell engager-based immunotherapies

May 3, 2022

Hemispherian closes seed funding to advance preclinical pipeline for cancer

May 3, 2022

Identification of human MAb that broadly neutralizes sarbecoviruses unveils a crucial CDRH3 motif

May 3, 2022

S trimer-engaging multivalent protein neutralizes SARS-CoV-2 variants and protects mice

May 3, 2022

Allogeneic colorectal cancer vaccine active against anti-PD-1-resistant colon cancer

May 3, 2022

Serine/threonine-protein kinase Pim-1 inhibitors identified at Japan Tobacco

May 3, 2022

Lilly patents dopamine D1 receptor positive allosteric modulators

May 3, 2022

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 10, 2026.
Hengrui discovers new Nav1.8 blockers
BioWorld Science
Researchers from Jiangsu Hengrui Pharmaceuticals Co. Ltd. and Shanghai Hengrui Pharmaceutical Co. Ltd. have patented new sodium channel protein type 10 subunit α...
Hematopoietic stem cell research points to leukemia’s early roots
BioWorld Science
Hematopoietic stem cell (HSC) research over the past century has shown that leukemia may be driven by an invisible hand of inflammation. The bone marrow and...
News in brief
BioWorld Asia
BioWorld Asia briefs for April 7, 2026
Korsana boosts Alzheimer’s work with reverse merger, $380M financing
BioWorld Science
Just over a month after emerging from stealth and disclosing a $150 million series A, Korsana Biosciences Inc. is making the leap to the public market via a...